Recent News

Alyve Medical Announces Publication of Clinical Trial on Neuralign S in the Treatment of Posterior Shoulder Instability

Study confirms the clinical benefits of incorporating treatment with Neuralign S into rehabilitation protocols for patients with posterior shoulder instability.

Read this post

Alyve Medical Awarded Most Fundable Company Recognition by Pepperdine Graziadio Business School

Denver, CO – Alyve Medical, a global medical technology company and leader in data-driven joint kinematics tools and personalized neuromuscular electrical stimulation (NMES) technologies, is delighted to announce that it has achieved Silver recognition on the Pepperdine Graziadio Business School’s sixth annual Most Fundable Companies® List.

Read this post

Alyve Medical Recognized as Finalist for the Digital Health Hub Foundation’s Digital Health Awards

Denver, CO — Alyve Medical, a global medical technology company and leader in data-driven joint kinematics tools and personalized neuromuscular electrical stimulation (NMES) technologies, is proud to announce its selection as a finalist for the Digital Health Awards, presented by the Digital Health Hub Foundation, held at the global leading healthcare conference, HLTH. Alyve Medical […]

Read this post

Alyve Medical Recognized as Quarterfinalist for the Digital Health Hub Foundation: Digital Health Awards

Denver, CO — Alyve Medical is thrilled to announce its selection as a quarterfinalist for the prestigious Digital Health Awards, presented by the Digital Health Hub Foundation. Alyve was chosen as a quarterfinalist for the Best in Class track in Surgical Transformation. The Digit Health Hub foundation highlighted the selection in a video announcement on […]

Read this post

Alyve Medical™ Announces New Headquarters and Launch of Rental Program for Neuralign S™ @Home

DENVER, CO – Alyve Medical Inc. is pleased to announce the establishment of its new global headquarters in Denver, CO as well as the launch of a home rental program for Neuralign S.

Read this post

Neuralign S™ Clinical Study Receives Another Best Paper Award at the SECEC-ESSSE Annual Congress

DUBLIN – The results of the randomized controlled trial on Neuralign S (formerly Shoulder Pacemaker) in the treatment of functional posterior shoulder instability has been awarded yet another award for Best Paper. This time at the SECEC-ESSSE (European Society for Surgery of the Shoulder and Elbow) 2022 Annual Congress in Dublin.

Read this post

Neuralign S™ Clinical Study Awarded Best Paper at DVSE Annual Congress

MUNICH – Alyve Medical™ congratulates Prof. Philipp Moroder and Prof. Laurent Audigé on receiving the award for Best Paper at the D-A-CH Vereinigung für Schulter- und Ellenbogenchirurgie e. V. (German-Austrian-Swiss Society for Shoulder and Elbow Surgery) Annual Congress in Munich.

Read this post

Alyve Medical™ Delivers Breakthrough Investor Presentation at Venture Summit West

SAN FRANCISCO – Alyve Medical Inc. recently became one of only 200 companies worldwide to earn a coveted presentation slot at the 10th annual Venture Summit West.

Read this post

Alyve Medical Inc. Appoints New CEO

Alyve Medical Inc. (formerly NCS America, Inc.), a global medical technology company and leader in data-driven joint kinematics tools, and personalized neuromuscular electrical stimulation (NMES) technologies, today announced that Yvonne Bokelman has been appointed its Chief Executive Officer.

Read this post

NCS America, Inc. Announces Name Change to Alyve Medical Inc.

NCS America, Inc. a global medical technology company and leader in data-driven joint kinematics tools and personalized neuromuscular electrical stimulation (NMES) technologies, announced today that it is changing its name to Alyve Medical Inc.

Read this post

NCS America, Inc. launches the Shoulder Pacemaker after receiving FDA clearance

NCS America, Inc. a world leader in developing technology to help diagnose, treat and prevent musculoskeletal injuries, today announced the expansion of their breakthrough product offerings with the FDA clearance of the Shoulder Pacemaker and its patented Motion Activated Stimulation™ (MAS) technology.

Read this post

@2022 Alyve Medical | All Rights Reserved | Privacy